Yuan Li

Serum thymidine kinase 1 levels predict cancer-free survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer

S. Eriksson, Lili Tang, E. He, 2013, Molecular and clinical oncology.

Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management.

Staffan Eriksson, Ji Zhou, Ellen He, 2009, Molecular medicine reports.

Temporal Heterogeneity of ROS1 Fusion and Braf Fusion Conferred Resistance to First-and Third-generation EGFR Tkis: a Case Report.

Liya Guan, Yihua Huang, Yuan Li, 2020 .